Prognostic biomarkers in patients with human immunodeficiency virus‐positive disease with head and neck squamous cell carcinoma
Hongzheng Zhang(Zhujiang Hospital), Dong M. Shin(Emory University), Heather M. Walline(University of Michigan), Gypsyamber DʼSouza(Johns Hopkins University), William H. Westra(Mount Sinai Hospital), Gabriel Sica(Emory University), Nabil F. Saba(Emory University), Emily L. Bellile(University of Michigan), Zhengjia Chen(Hunan University of Traditional Chinese Medicine), Martin P. Graham(University of Michigan), Jonathan B. McHugh(University of Michigan), Minh Ly Nguyen(Emory University), Christine M. Komarck(University of Michigan), Raja R. Seethala(University of Pittsburgh), Charles E. Moore(Emory University), Lisa A. Peterson(University of Minnesota), Sara I. Pai(Yale University), Amy Y. Chen(Vector (United States)), William N. William(The University of Texas MD Anderson Cancer Center), Thomas E. Carey(University of Michigan), Adel K. El‐Naggar(Barking, Havering And Redbridge University Hospitals NHS Trust), Gregory T. Wolf(University of Michigan), Robert L. Ferris(University of Pittsburgh), Jennifer R. Grandis(University of California, San Francisco), Sreenivas Nannapaneni(GlaxoSmithKline (United States)), James Riddell(University of Michigan), Sungjin Kim(Cedars-Sinai Medical Center), Zhuo Georgia Chen(Emory University), David Sidransky(University of Baltimore), Marina Mošunjac(Emory University Hospital)
Cited by 9
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Head and neck squamous cell carcinoma
|Nature Reviews Disease Primers|2020|4k
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
|New England Journal of Medicine|2007|1.7k